top of page

Yinnong Jia

Research Fellow

Research interest

Receptor targeting, multimodal imaging probes, antiviral treatment, peptide-based radiopharmaceutics and theranostics

Education background

Liang Zhao_edited_edited.jpg

PhD, Pharmaceutical Sciences, University of Nebraska Medical Center, United States, 2017

B.Sc. Pharmaceutical Sciences, Shenyang Pharmaceutical University, China, 2011

​

Email: jiayinnong@kmmu.edu.cn

Publication

  1. Yang T, Gao W, Ma X, Liu Q, Pang P, Zheng Y, Jia Y#, Zheng C#. A Review on The Pathogenesis of Cardiovascular Disease of Flaviviridea Viruses Infection. Viruses 2024, 16, 365. https://doi.org/10.3390/v16030365

  2. Wu J, Yuan S, Jiang Y, Jia Y#, Ji C, Tan Z, Shi W, Peng Z#. Alendronate-derived carbon dots for bioimaging and effective osteoblastic differentiation induction and promotion. Diamond and Related Materials. 2023;140. 110571.

  3. Jiang Y, Tan Z, Zhao T, Wu J, Li Y, Jia Y #, Peng Z#.Indocyanine Green derived Carbon Dots with Significantly Enhanced Properties for Efficient Photothermal Therapy, Nanoscale, 2023, 15(4): 1925-1936.

  4. Ma X*, Jia Y*, Yuan J, Tang Q, Gao W, Zhou G, Yang R, Pang W, Zheng C. Inhibiting cardiac autophagy suppresses Zika virus replication. J Med Virol. 2023; 95:e28483.

  5. Gao Y*, Jia Y*, Yu Z, Ji X, Liu X, Han L, Zhang H, Zhu B, Xu M. Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA database. Eur J Med Res 28, 103 (2023).

  6. Tan Z, Sun W, Li Y, Jiao X, Zhu M, Zhang J, Qing C, Jia Y. Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis, Biomolecules, 2022, 12: 1273.

  7. Tan Z, Huang H, Sun W, Li Y, Jia Y. Current progress of ferroptosis study in ovarian cancer. Front Mol Biosci. 2022 Aug 26;9:966007.

  8. Jia Y, Zhang W, Fan W, Brusnahan S, Garrison J. Investigation of the Biological Impact of Charge Distribution on a NTR1-Targeted Peptide. Bioconjugate Chemistry. 2016,27(11), pp 2658–2668.

  9. Jia Y, Shi W, Zhou Z, Wagh N, Fan W, Brusnahan S, Garrison J. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting. Nuclear medicine and biology. 2015; 42(11), 816-823.


bottom of page